OR WAIT null SECS
Transferring Energy to Hot Melt Extrusion
A greater understanding of molecular and cellular biology and technological advancements are revolutionizing the field of biologics.
The use of appropriate taste-masking and appearance technologies can facilitate patient compliance.
A comparison between polysorbates and HPβCD determines the better stabilizer for biologics formulation.
This study reviews changes in in-country testing (registration testing, import testing) requirements and analyzes current trends.
Guidance documents and interaction with FDA can help manufacturers stay in GMP compliance, says Siegfried Schmitt, VP Technical, at Parexel.
A Closer Look at mRNA in Oncology and Vaccines
May 24, 2024
With the acquisition, Biogen gains felzartamab, HI-Bio's lead investigational mAb candidate being developed for the treatment of a range of immune-mediated diseases.
With this acquisition, Merck KGaA will have the capability to offer integrated services for viral vector manufacturing.
May 23, 2024
The units are being recalled because of incomplete crimp seals and one complaint of a leaking unit.
May 22, 2024
The company is collaborating with the Access to Oncology Medicines Coalition to expand patient access to immuno-oncology therapy Opdivo.
May 20, 2024
The new facility will be the company’s first to offer full manufacturing processing for antibody drug conjugates.
After a review, the agency concluded there was a possible risk of cancer to those exposed to 17-hydroxyprogesterone caproate in the womb.
May 18, 2024
Bari Kowal, senior vice-president, head Development Operations & Portfolio Management, Regeneron, discussed the utility of AI and how it can benefit R&D work.
A combination of rapid sterility methods with the industry standard compendial method should ensure maximum safety.
May 17, 2024
Ken Keller, president and CEO, Daiichi Sankyo, discusses the foundation of partnership and takes a look at the future of biotech partnerships at the US Pharma and Biotech Summit.
TekniPlex recently acquired Seisa Medical, which has expanded the company's services into that of a CDMO.